Nocimed harnesses the existing power of Magnetic Resonance Spectroscopy (MRS) for non-invasive, objective quantification of relative chemical differences in tissues applied to assess the relative chemical biomarkers for tissue degeneration and pain. Our focus is to compare relative differences in these degenerative pain biomarkers between lumbar discs in patients receiving MRS exams of those tissues.
CE Marked.
CAUTION (United States): Federal law restricts this device to sale by or on the order of a physician. Note: Statement applicable to NOCICALC-LS only in the United States.
The NOCISCAN Suite is compromised of the NOCICALC-LS and NOCIGRAM-LS post-processing products.
CE Marked.
CAUTION (United States): Federal law restricts this device to sale by or on the order of a physician. Note: Statement applicable to NOCICALC-LS only in the United States.
The NOCISCAN Suite is compromised of the NOCICALC-LS and NOCIGRAM-LS post-processing products.
Location: United States, California, San Mateo
Employees: 11-50
Founded date: 2015